PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Medication abortion safety and effectiveness with misoprostol alone

JAMA Network Open

2023-10-27
(Press-News.org)

About The Study: The findings in this study of 637 callers to safe abortion hotlines and accompaniment groups in Argentina, Nigeria, and Southeast Asia suggest that misoprostol alone is a highly effective method of pregnancy termination. Future research should explore strategies to maximize the effectiveness of misoprostol alone in clinical and nonclinical settings. 

Authors: Ruvani Jayaweera, Ph.D., of Ibis Reproductive Health in Oakland, California, is the corresponding author. 

 To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2023.40042)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.40042?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=102723

END



ELSE PRESS RELEASES FROM THIS DATE:

SwRI, GTI Energy, GE celebrate mechanical completion of $155 million supercritical CO2 pilot plant

SwRI, GTI Energy, GE celebrate mechanical completion of $155 million supercritical CO2 pilot plant
2023-10-27
SAN ANTONIO — October 27,2023 —Southwest Research Institute (SwRI®), GTI Energy, GE Vernova (GE) and the U.S. Department of Energy celebrated the ribbon-cutting of the Supercritical Transformational Electric Power (STEP) Demo pilot plant today. The $155 million, 10-megawatt supercritical carbon dioxide (sCO2) test facility at SwRI’s headquarters in San Antonio will demonstrate an innovative new method of higher-efficiency, lower-cost electric power generation. “STEP will undoubtedly change the way we think about ...

Innovative research aims to improve wound healing and cancer therapy

Innovative research aims to improve wound healing and cancer therapy
2023-10-27
Jun.-Prof. Dr. Priscilla Briquez, junior professor at the Department of General and Visceral Surgery at the Freiburg University Medical Center and member of the Medical Faculty at the University of Freiburg, has received a European Research Council (ERC) Starting Grant from the European Commission. Her DRESSCODE project will receive a total of 1.5 million euros funding for five years. The project focuses on modifying proteins and developing new disease therapies. “This support is a major opportunity for me to put together my own team and drive forward my research,” says Briquez. The focus ...

Action plan for better data on migration and health

Action plan for better data on migration and health
2023-10-27
Despite rising global mobility, the state of migrant and refugee health data in European health systems is a concern, a new study shows. The analysis by an international coalition of universities, UN organizations, government representatives, and European institutions published in the journal The Lancet Regional Health Europe reveals that coverage of migrant and refugee data remains inconsistent and of suboptimal quality. According to the study this issue is not due to a lack of knowledge or technological resources ...

FDA approves muscular dystrophy drug built on Children’s National research 

2023-10-27
WASHINGTON (October 27, 2023) – Boys with Duchenne muscular dystrophy (DMD) have a clinically proven, new treatment option with the Food and Drug Administration’s approval Thursday of vamorolone, a steroidal-type, anti-inflammatory drug developed based on research performed at Children’s National Hospital.    Created by ReveraGen BioPharma Inc., vamorolone has a molecular structure similar to traditional corticosteroids, which are currently used to treat DMD. Yet its structure was found to be chemically different enough to reduce unwanted side effects, including brittle bones and reduced stature. Nearly two decades ago, ReveraGen leaders – President and ...

Electrodes with hollow nanotubes improve performance of potassium-ion batteries

Electrodes with hollow nanotubes improve performance of potassium-ion batteries
2023-10-27
Researchers who are working to find alternatives to lithium-ion batteries have turned their attention to potassium-ion batteries. Potassium is an abundant resource and the technology functions in much the same way as lithium-ion batteries, but these batteries have not been developed at a large scale because the ionic radius causes problems in energy storage and substandard electrochemical performance.   To solve this problem, researchers are considering NiCo2Se4, a bimetallic selenide, to create sphere-shaped electrodes. The spheres are constructed with NiCo2Se4 nanotubes, which improve ...

USDA grant will help MU researchers address opioid epidemic in rural Missouri

USDA grant will help MU researchers address opioid epidemic in rural Missouri
2023-10-27
COLUMBIA, Mo. -- Childhood trauma is a key risk factor for future substance use disorder, overdose, and suicide. This is particularly problematic in rural areas where children experience higher rates of adverse childhood experiences (ACEs). ACEs are commonly defined as physical and emotional abuse and neglect, sexual abuse, parental separation or divorce, intimate partner violence, and having household members with serious mental illness, substance use disorder, or a history of incarceration. Now, a three-year, U.S. Department of Agriculture (USDA) grant awarded to the University of Missouri will help virtually train various members of the workforce — ...

UiB researchers solve protein mystery

UiB researchers solve protein mystery
2023-10-27
Proteins are key to all processes in our cells and understanding their functions and regulation is of major importance. “For many years, we have known that nearly all human proteins are modified by a specific chemical group, but its functional impact has remained undefined”, says professor Thomas Arnesen at the Department of Biomedicine, University of Bergen. He explains: “One of the most common protein modifications in human cells is N-terminal acetylation, which is an addition of a small chemical group (acetyl) at the starting tip (N-terminus) of a protein. The ...

Protein root discovery seals future of climate proof plants

2023-10-27
Researchers have discovered a protein that seals plant roots to regulate the uptake of nutrients and water from the soil, the discovery could help develop climate proof crops that require less water and chemical fertilizers. Researchers from the University of Nottingham identified new components of the lignin barrier in plant roots and the specific function of dirigent proteins (DPs), located in the root endodermis that control water and nutrient uptake. Their findings have been published today in Science Direct. Plant roots function by absorbing ...

A relational framework for microbiome research that includes Indigenous communities

2023-10-27
Research on the trillions of microorganisms that make up a person’s microbiome can lead to medical breakthroughs to treat diseases like inflammatory bowel syndrome and diabetes. According to Alyssa Bader, a Tsimshian Assistant Professor in the Department of Anthropology at McGill University, microbiome samples from Indigenous communities have the potential to further Western medicine, but those same communities often have been excluded from the research process and may miss out on the benefits that result from their contributions to science. ...

City of Hope part of successful international Phase 3 clinical trial evaluating sotorasib medication combination for patients with metastatic colorectal cancer

City of Hope part of successful international Phase 3 clinical trial evaluating sotorasib medication combination for patients with metastatic colorectal cancer
2023-10-27
LOS ANGELES — An international Phase 3 clinical trial found that metastatic colorectal cancer patients with a rare genetic tumor mutation called KRAS G12C experienced superior progression-free survival rates compared to standard of care when offered a combination treatment of KRAS inhibitor sotorasib and monoclonal antibody panitumumab. City of Hope, one of the largest cancer research and treatment organizations in the United States, was a participating site and a City of Hope researcher is the lead author of the The New England Journal of Medicine study published this week. Standard ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Medication abortion safety and effectiveness with misoprostol alone
JAMA Network Open